Resources
MS News (Y!)
multiple-sclerosis - Yahoo! News Search Results
URL: http://msbuzz.org/
Updated: 12 hours 39 min ago
PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022
NEW YORK, May 16, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market ...
Categories: News
Research and Markets: Laquinimod (Multiple Sclerosis) - Forecast and Market Analysis to 2022
Research and Markets has announced the addition of the "Laquinimod - Forecast and Market Analysi
Categories: News
Research and Markets: Tcelna (Multiple Sclerosis) - Forecast and Market Analysis to 2022
Research and Markets has announced the addition of the "Tcelna - Forecast and Market Analys
Categories: News
Research and Markets: Avonex (Multiple Sclerosis) - Forecast and Market Analysis to 2022
Research and Markets has announced the addition of the "Avonex - Forecast and Market Analys
Categories: News
Research and Markets: BG-12 (Multiple Sclerosis) - Forecast and Market Analysis to 2022
Research and Markets has announced the addition of the "BG-12 - Forecast and Market Analysis
Categories: News
Research and Markets: Betaseron/Betaferon (Multiple Sclerosis) - Forecast and Market Analysis to 2022
Research and Markets has announced the addition of the "Betaseron/Betaferon - Forecast an
Categories: News
Research and Markets: Lemtrada (Multiple Sclerosis) - Forecast and Market Analysis to 2022
Research and Markets has announced the addition of the "Lemtrada - Forecast and Market Analysis to
Categories: News
PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis to 2022
NEW YORK, May 14, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis ...
Categories: News
PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022
NEW YORK, May 14, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis ...
Categories: News
PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022
NEW YORK, May 14, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis ...
Categories: News
Research and Markets: PharmaPoint: Multiple Sclerosis - Spain Drug Forecast and Market Analysis to 2022
Research and Markets has announced the addition of the "PharmaPoint: Multiple Sclerosis - Spain Drug Forecast and Ma
Categories: News
Research and Markets: Multiple Sclerosis Partnering 2007-2013 Out Now
Research and Markets has announced the addition of the "Multiple Sclerosis Partnering 2007-2013" report to their offeri
Categories: News
Research and Markets: Rebif (Multiple Sclerosis) - Forecast and Market Analysis to 2022
Research and Markets has announced the addition of the "Rebif - Forecast and Market Analysis
Categories: News
Research and Markets: NU-100 (Multiple Sclerosis) - Forecast and Market Analysis to 2022
Research and Markets has announced the addition of the "NU-100 - Forecast and Market Analysi
Categories: News
Research and Markets: Masitinib (Multiple Sclerosis) - Forecast and Market Analysis to 2022
Research and Markets has announced the addition of the "Masitinib - Forecast and Market Analysis
Categories: News
Stanford: treatment delays multiple sclerosis onset in mice
by Elena Kadvany Researchers from the Stanford University School of Medicine discovered that blocking the expression of a single protein in the brains of mice with a form of multiple sclerosis delays the onset of paralysis.
Categories: News
On May 26th, Quebec Walks for Multiple Sclerosis!
MONTREAL , May 13, 2013 /CNW Telbec/ - For the first time in its history, the MS Walk will be held on the same day in 22 cities in Quebec . The Multiple Sclerosis Society of Canada invites you to mark ...
Categories: News
PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022
NEW YORK, May 13, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis ...
Categories: News
PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis to 2022
NEW YORK, May 13, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis ...
Categories: News
PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022
NEW YORK, May 13, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis ...
Categories: News



